CLIS:TASEClal Insurance Enterprises Holdings Limited Analysis

Clal Insurance is trading at 25,450, comfortably above its 20‑day (25,165.5), 50‑day (23,300.6) and 200‑day (17,196.7) moving averages, indicating a short‑term bullish bias. The price sits near the upper end of its range, with a key resistance at 27,450 and support at 22,690, while the RSI of 54.7 suggests momentum is still neutral. However, the MACD histogram is negative (-26.9) and the signal line is bearish, hinting at a possible near‑term pullback despite the overall bullish trend and increasing volume.
Fundamentally, the stock appears overvalued: the trailing P/E of 23.7 exceeds the industry average of 17.1, the price‑to‑book ratio is an extreme 202×, and the DCF‑derived fair value (≈21,653) is well below the current market price. Revenue is growing at 9.1% year‑over‑year and operating margins are strong at 38%, yet profitability is thin (3.3% net margin) and free cash flow is negative, while debt‑to‑equity sits at a high 154%, raising concerns about balance‑sheet resilience.
The dividend yield of 1.47% with a 35% payout ratio is modestly sustainable given positive operating cash flow, but the heavy leverage and volatile 30‑day price swings (≈50% volatility) amplify risk. The Fear & Greed Index indicates “Extreme Greed,” suggesting market optimism may be overstated. Overall, the stock’s upside is capped by valuation pressure and structural debt, while downside risk is moderated by solid earnings and a stable dividend.